Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux

Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett's oesophagus with low-grade dysplasia

(2017) Massimiliano di Pietro et al.   GUT

Acceptability of the Cytosponge procedure for detecting Barrett's oesophagus: a qualitative study

(2017) Madeleine Freeman et al.   BMJ Open

54 Evaluation of a Minimally-Invasive Cytosponge Esophageal Cell Collection System in Patients With Barrett's Esophagus

(2015) Pierre Lao-Sirieix et al.   GASTROENTEROLOGY

Methods for sample size determination in cluster randomized trials

(2015) Clare Rutterford et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma

(2015) Caryn S Ross-Innes et al.   NATURE GENETICS

Precision prevention of oesophageal adenocarcinoma

(2015) Thomas L. Vaughan et al.   Nature Reviews Gastroenterology & Hepatology

Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett's Esophagus: A Multi-Center Case–Control Study

(2015) Caryn S. Ross-Innes et al.   PLOS MEDICINE

Radiofrequency Ablation vs Endoscopic Surveillance for Patients With Barrett Esophagus and Low-Grade Dysplasia

(2014) K. Nadine Phoa et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Variation in gastroscopy rate in English general practice and outcome for oesophagogastric cancer: retrospective analysis of Hospital Episode Statistics

(2013) Mustafa Shawihdi et al.   GUT

British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus

(2013) Rebecca C Fitzgerald et al.   GUT

Health Benefits and Cost Effectiveness of Endoscopic and Nonendoscopic Cytosponge Screening for Barrett's Esophagus

(2012) Tatiana Benaglia et al.   GASTROENTEROLOGY

Esophageal Adenocarcinoma Incidence: Are We Reaching the Peak?

(2010) H. Pohl et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Non-endoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic

(2009) P Lao-Sirieix et al.   GUT